SCHEMBL8631337

SCHEMBL8631337

C=CCn1nc(NS(=O)(=O)c2ccccc2)c(-c2ccc(C)cc2)c1C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.42
TDP2 O95551 1/20 0.42
POLB P06746 1/20 0.42
HSP90AA1 P07900 1/20 0.42
HPGD P15428 1/20 0.42
BLM P54132 1/20 0.42
UBE2I P63279 1/20 0.42
ATM Q13315 1/20 0.42
SAE1 Q9UBE0 1/20 0.42
UBA2 Q9UBT2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 4/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
NPY5R Q15761 1/20 0.38
LMNA P02545 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8627799 0.93 PTGS2 (0.49) PTGS2SMN1; SMN2KMT2AMAPTMEN1
SCHEMBL8629864 0.92 PTGS2 (0.42) PTGS2SMN1; SMN2TDP2POLBHSP90AA1
SCHEMBL8631550 0.91 PTGS2 (0.58) PTGS2POLBKMT2AMAPTMEN1
SCHEMBL8629761 0.90 PTGS2 (0.48) PTGS2POLBKMT2AMAPTMEN1
SCHEMBL8635116 0.89 PTGS2 (0.48) PTGS2SMN1; SMN2POLBKMT2AMAPT
SCHEMBL8634392 0.89 PTGS2 (0.48) PTGS2SMN1; SMN2POLBHPGDKMT2A
SCHEMBL8628753 0.88 PTGS2 (0.46) PTGS2SMN1; SMN2TDP2POLBHSP90AA1
SCHEMBL8630021 0.88 SMN1; SMN2 (0.49) PTGS2SMN1; SMN2HPGDKMT2AMAPT
SCHEMBL8634434 0.86 SMN1; SMN2 (0.45) SMN1; SMN2TDP2POLBHSP90AA1HPGD
SCHEMBL8631097 0.86 PTGS2 (0.43) PTGS2SMN1; SMN2TDP2POLBHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed